Skip to content

Jiawei Xiaoyao granule for depression patients with liver depression and and spleen deficiency syndrome

Study on the pathogenetic mechanism of liver depression and spleen deficiency syndrome by metagenomics

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011108
Enrollment
Unknown
Registered
2017-04-10
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

experimental group:Jiawei Xiaoyao granule
control group:placebo

Sponsors

The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Conforms to diagnostic criteria of light or moderate depressive episode in the diagnostic and statistical manual of mental disorders (fifth edition) (DSM - 5); 2. Conform to the diagnostic criteria of depression patients with liver depression and and spleen deficiency syndrome in the Chinese medicine internal medicine disease treatment guidelines; 3. Aged 18 to 60 years male and female; 4. Subjects are informed, voluntary signing informed consent.

Exclusion criteria

Exclusion criteria: hypertension; cardiovascular disease; diabetes mellitus; obesity; liver cirrhosis;fatty liver disease; irritable bowel syndrome; inflammatory bowel disease; drug or alcohol abuse in the last year; use of antibiotics,probiotics, prebiotics, or synbiotics in the month before collection of the fecal sample; and known active bacterial, fungal, or viralinfections.

Design outcomes

Primary

MeasureTime frame
Hamilton depressionrating scale (HAMD);Patient Health Questionnaire-9(PHQ-9);TCM symptom assessment;

Secondary

MeasureTime frame
The world health organization quality of life measurement scale short form (WHOQOL BREF);

Countries

China

Contacts

Public ContactYu Lin

The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital)

yulinfimmu@126.com+86 020-81774651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026